Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

F. Aberer; S. Kremser; J. K. Mader; W. Zinke-Cerwenka; H. Greinix; N. J. Tripolt; T. R. Pieber; A. Zebisch; H. Sill; A. Oulhaj; H. Sourij; A. Wölfler

doi:10.1016/j.diabet.2017.02.001

Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

F. Aberer
, S. Kremser
, J. K. Mader
, W. Zinke-Cerwenka
, H. Greinix
, N. J. Tripolt
, T. R. Pieber
, A. Zebisch
, H. Sill
, A. Oulhaj
, H. Sourij
, A. Wölfler

Medical University of Graz
Center for Biomarker Research in Medicine (CBmed)

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	560-562
Number of pages	3
Journal	Diabetes and Metabolism
Volume	43
Issue number	6
DOIs	https://doi.org/10.1016/j.diabet.2017.02.001
State	Published - Dec 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.diabet.2017.02.001

Cite this

Aberer, F., Kremser, S., Mader, J. K., Zinke-Cerwenka, W., Greinix, H., Tripolt, N. J., Pieber, T. R., Zebisch, A., Sill, H., Oulhaj, A., Sourij, H., & Wölfler, A. (2017). Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia. Diabetes and Metabolism, 43(6), 560-562. https://doi.org/10.1016/j.diabet.2017.02.001

@article{6b08cef8cde34ee58c6437d5a6f5458f,

title = "Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia",

author = "F. Aberer and S. Kremser and Mader, \{J. K.\} and W. Zinke-Cerwenka and H. Greinix and Tripolt, \{N. J.\} and Pieber, \{T. R.\} and A. Zebisch and H. Sill and A. Oulhaj and H. Sourij and A. W{\"o}lfler",

year = "2017",

month = dec,

doi = "10.1016/j.diabet.2017.02.001",

language = "English",

volume = "43",

pages = "560--562",

journal = "Diabetes and Metabolism",

issn = "1262-3636",

publisher = "Elsevier Masson s.r.l.",

number = "6",

}

Aberer, F, Kremser, S, Mader, JK, Zinke-Cerwenka, W, Greinix, H, Tripolt, NJ, Pieber, TR, Zebisch, A, Sill, H, Oulhaj, A, Sourij, H & Wölfler, A 2017, 'Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia', Diabetes and Metabolism, vol. 43, no. 6, pp. 560-562. https://doi.org/10.1016/j.diabet.2017.02.001

TY - JOUR

T1 - Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

AU - Aberer, F.

AU - Kremser, S.

AU - Mader, J. K.

AU - Zinke-Cerwenka, W.

AU - Greinix, H.

AU - Tripolt, N. J.

AU - Pieber, T. R.

AU - Zebisch, A.

AU - Sill, H.

AU - Oulhaj, A.

AU - Sourij, H.

AU - Wölfler, A.

PY - 2017/12

Y1 - 2017/12

UR - https://www.scopus.com/pages/publications/85014437672

U2 - 10.1016/j.diabet.2017.02.001

DO - 10.1016/j.diabet.2017.02.001

M3 - Letter

C2 - 28279650

AN - SCOPUS:85014437672

SN - 1262-3636

VL - 43

SP - 560

EP - 562

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

IS - 6

ER -

Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia

UN SDGs

Access to Document

Other files and links

Cite this